Miolastan

Roman name

Myolastan

The composition and the form of

1 tablet contains tetrazepama 50 mg; blistere in 10 pcs. , in box 2 blisters.

Indications

Contracture of the degenerative spine lesions, neurological contracture of the spasm, wryneck, pain in the back or lower back.

Contraindications

Hypersensitivity, severe respiratory distress, pregnancy.

Side-Effects

Drowsiness, irritability, aggressiveness, the slowdown in the rate of reaction, infants, the symptoms (anxiety mialgia, insomnia, nightmares, neuralgia, convulsions), rash.

Patient interaction

Do (mutually) effects miorelaksantov, Neuroleptics, tranquilizers, antidepressants, alcohol, sedatives, hypnotics funds.

Precautions

There is a need for caution and strict medical control in the treatment of patients with myasthenia. It should be borne in mind reduced rate of the reaction. Nursing mothers at the time of treatment should stop breastfeeding.

Dosing and Administration

Inside. 1st day on 1/2-1 table. (25-50 mg), it is desirable evening. Then, gradually increasing the dose 1/2-1 table. on the day-to 3-6 (in exceptional cases up to 8) table. per day in 3-4 reception. For children 4 mg / kg per day. The duration of treatment should be limited.

Storage conditions

At room temperature

Shelf life

3 years

The registration

008,123 (Ann.2002)

Directory → Neurotropic funds → Funds affecting neuromuscular transmission → Miolastan